Cambridge Investment Research Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-6,850
| Closed | -$1.49M | – | 3199 |
|
|
2021
Q1 | $1.49M | Sell |
6,850
-19,838
| -74% | -$4.3M | 0.01% | 1183 |
|
|
2020
Q4 | $3.08M | Sell |
26,688
-2,879
| -10% | -$332K | 0.02% | 706 |
|
|
2020
Q3 | $2.88M | Buy |
29,567
+9,192
| +45% | +$895K | 0.02% | 639 |
|
|
2020
Q2 | $2.5M | Sell |
20,375
-1,008
| -5% | -$124K | 0.02% | 678 |
|
|
2020
Q1 | $1.87M | Buy |
21,383
+10,598
| +98% | +$928K | 0.02% | 698 |
|
|
2019
Q4 | $1.13M | Buy |
10,785
+1,009
| +10% | +$106K | 0.01% | 1079 |
|
|
2019
Q3 | $1.13M | Sell |
9,776
-530
| -5% | -$61K | 0.01% | 1005 |
|
|
2019
Q2 | $1.78M | Sell |
10,306
-838
| -8% | -$144K | 0.02% | 768 |
|
|
2019
Q1 | $1.88M | Buy |
11,144
+744
| +7% | +$125K | 0.02% | 741 |
|
|
2018
Q4 | $1.01M | Buy |
10,400
+4,630
| +80% | +$451K | 0.01% | 929 |
|
|
2018
Q3 | $997K | Buy |
5,770
+91
| +2% | +$15.7K | 0.01% | 1030 |
|
|
2018
Q2 | $792K | Buy |
5,679
+2,273
| +67% | +$317K | 0.01% | 1116 |
|
|
2018
Q1 | $384K | Buy |
3,406
+1,224
| +56% | +$138K | ﹤0.01% | 1499 |
|
|
2017
Q4 | $288K | Sell |
2,182
-127
| -6% | -$16.8K | ﹤0.01% | 1685 |
|
|
2017
Q3 | $234K | Buy |
2,309
+189
| +9% | +$19.2K | ﹤0.01% | 1717 |
|
|
2017
Q2 | $213K | Buy |
+2,120
| New | +$213K | ﹤0.01% | 1717 |
|
|
2014
Q4 | – | Sell |
-2,668
| Closed | -$216K | – | 1511 |
|
|
2014
Q3 | $216K | Buy |
+2,668
| New | +$216K | 0.01% | 1262 |
|